17 March 2021: One year into Covid-19, ICGEB Principal Investigators from Trieste, New Delhi, and Cape Town present their research and work in the field at the ICGEB Symposium.
Organised by Lawrence Banks, ICGEB Director-General, the ICGEB Covid-19 Symposium kicked off with Alessandro Marcello, Group Leader, Molecular Virology, presenting the work of his team over the past year on developing antivirals for SARS-CoV-2.
Other speakers, Anmol Chandele, ICGEB-Emory Vaccine Program, provided an overview of the pandemic in India and presented her team’s work on the characterisation of antibody responses in COVID-19 recovered individuals.
Mauro Giacca, Molecular Medicine ICGEB, reported on drugs that block SARS-CoV-2 Spike-induced cellular syncytia; exciting work that has evolved from an initial collaboration with the Cattinara University Hospital and the University of Trieste and continues to celebrate the power of screening.
The sessions continued throughout the morning with Arockiasamay Arulandu, Dinesh Gupta, and Sujatha Sunil from ICGEB New Delhi, Natasa Skoko, Serena Zacchigna, and Emanuele Buratti, ICGEB Trieste, and Georgia Schafer speaking on the generation of SARS-CoV2 pseudovirions and their application in neutralisation assays, from ICGEB Cape Town.
Symposiums have been an annual event for over 20 years at ICGEB and provide an opportunity for our scientists and staff to come together and hear about the current research, results, and developments in fields of cutting-edge topics in the Life Sciences underway in our labs. This is the first edition taking place online – giving us all a front seat view and the chance to take part collectively; also to witness the fermentation of ideas, through Q&A that takes place across the labs.
